Heyrosa Mary Grace, Melniczek David M, Rovito Peter, Nicholas Gary G
Department of Surgery, Lehigh Valley Hospital, Allentown, PA 18105, USA.
J Am Coll Surg. 2006 Apr;202(4):618-22. doi: 10.1016/j.jamcollsurg.2005.12.009.
Percutaneous dilational tracheostomy (PDT) is becoming a widely accepted technique that has replaced open tracheostomy (OT) in many hospitals. One of the remaining relative contraindications is morbid obesity. There are no published case series of its use in this patient population. We reviewed our experience with PDT in the morbidly obese and compared it to OT in this patient population. Our hypothesis is that PDT and OT have a similar frequency of adverse events.
We reviewed charts of all morbidly obese patients (body mass index [BMI]>or=35, calculated as kg/m2) undergoing either PDT or OT at our institution during a 58-month period. Variables examined included age, gender, BMI, diagnosis, bedside or operating room, and bronchoscopy-assisted. We recorded all procedural complications and all tracheostomy-related complications that occurred for 30 days postprocedure or death. Primary adverse end points were defined as procedures that started percutaneous and converted to open; any reoperation related to the initial tracheostomy; malpositioning of tracheostomy resulting in patient morbidity, loss of airway control, and bleeding requiring surgical intervention. Secondary adverse end points occurred when a tracheostomy tube was dislodged or malfunctioned, as in the case of a cuff leak, and any bleeding that occurred more than 24 hours after insertion.
From January 1, 2000, until September 30, 2004, our institution performed 1,062 tracheostomies. One hundred forty-three patients had a BMI>or=35. Eighty-nine patients underwent PDT and 53 patients underwent OT. Sixty-seven of the PDTs were performed at the bedside and 22 were performed in the operating room. All OTs were performed in the operating room. Five (6.5%) primary end points were recorded for PDTs (4 conversions to open, 1 malpositioning). Three (6.5%) primary end points were reported for OTs (malpositioning resulting in hypoxia, bleeding requiring surgical intervention, aborted attempt at open).
PDT is a safe procedure to perform on morbidly obese patients.
经皮扩张气管切开术(PDT)正成为一种被广泛接受的技术,在许多医院已取代开放气管切开术(OT)。其尚存的相对禁忌证之一是病态肥胖。目前尚无关于在这类患者群体中应用该技术的已发表病例系列。我们回顾了我们在病态肥胖患者中应用PDT的经验,并将其与该患者群体中OT的经验进行比较。我们的假设是PDT和OT的不良事件发生率相似。
我们回顾了在58个月期间在我们机构接受PDT或OT的所有病态肥胖患者(体重指数[BMI]≥35,以千克/平方米计算)的病历。检查的变量包括年龄、性别、BMI、诊断、床边或手术室情况以及支气管镜辅助情况。我们记录了所有手术并发症以及术后30天内发生的所有与气管切开术相关的并发症或死亡情况。主要不良终点定义为开始经皮操作后转为开放手术的情况;任何与初始气管切开术相关的再次手术;气管切开位置不当导致患者发病、气道控制丧失以及需要手术干预的出血情况。次要不良终点发生在气管切开导管移位或出现故障时,如袖带漏气的情况,以及插入后24小时以上发生的任何出血情况。
从2000年1月1日至2004年9月30日,我们机构共进行了1062例气管切开术。143例患者的BMI≥35。89例患者接受了PDT,53例患者接受了OT。PDT中有67例在床边进行,22例在手术室进行。所有OT均在手术室进行。PDT记录到5例(6.5%)主要终点事件(4例转为开放手术,1例位置不当)。OT报告了3例(6.5%)主要终点事件(位置不当导致缺氧、需要手术干预的出血、开放手术尝试中止)。
PDT对病态肥胖患者来说是一种安全的手术操作。